[go: up one dir, main page]

TN2011000047A1 - Method of identifying disease risk factors - Google Patents

Method of identifying disease risk factors

Info

Publication number
TN2011000047A1
TN2011000047A1 TN2011000047A TN2011000047A TN2011000047A1 TN 2011000047 A1 TN2011000047 A1 TN 2011000047A1 TN 2011000047 A TN2011000047 A TN 2011000047A TN 2011000047 A TN2011000047 A TN 2011000047A TN 2011000047 A1 TN2011000047 A1 TN 2011000047A1
Authority
TN
Tunisia
Prior art keywords
active agent
risk factors
disease risk
genetic variant
identifying disease
Prior art date
Application number
TN2011000047A
Other languages
English (en)
Inventor
Allen D Roses
Original Assignee
Zinfandel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/053373 external-priority patent/WO2010019550A2/fr
Application filed by Zinfandel Pharmaceuticals Inc filed Critical Zinfandel Pharmaceuticals Inc
Publication of TN2011000047A1 publication Critical patent/TN2011000047A1/fr

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TN2011000047A 2009-08-11 2011-01-27 Method of identifying disease risk factors TN2011000047A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/053373 WO2010019550A2 (fr) 2008-08-12 2009-08-11 Procédé d'identification de facteurs de risque de maladie

Publications (1)

Publication Number Publication Date
TN2011000047A1 true TN2011000047A1 (en) 2012-09-05

Family

ID=55024361

Family Applications (1)

Application Number Title Priority Date Filing Date
TN2011000047A TN2011000047A1 (en) 2009-08-11 2011-01-27 Method of identifying disease risk factors

Country Status (1)

Country Link
TN (1) TN2011000047A1 (fr)

Similar Documents

Publication Publication Date Title
CA2735578C (fr) Methode de determination de facteurs de risque de la maladie d'alzheimer comprenant des variants du gene tomm40
NZ596614A (en) Diagnosis and treatment of alzheimer's disease
MX2009012722A (es) Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama.
AR088827A1 (es) Metodos para tratar, diagnosticar, y monitorear la enfermedad de alzheimer
NZ590833A (en) Genetic variants for breast cancer risk assessment
NZ593628A (en) Genetic variants useful for risk assessment of thyroid cancer using rs944289
EP2663656A1 (fr) Variants génétiques comme marqueurs à utiliser dans l'évaluation du risque, le diagnostic, le pronostic et le traitement du cancer de la vessie
NZ591613A (en) Polymorphic marker rs965513 for risk assessment of thyroid cancer
NZ590893A (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
WO2010018601A3 (fr) Variants génétiques prédictifs d’un risque de cancer
EP3219813A3 (fr) Procédés pour traiter, diagnostiquer, et surveiller le lupus
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
MX353428B (es) Métodos y composiciones para identificar y tratar lupus.
NZ598009A (en) Genetic markers associated with risk of diabetes mellitus
EA201291228A1 (ru) Биомаркер для детекции высокогорной адаптации и высокогорного отека легких
WO2012006056A3 (fr) Ccr6 en tant que biomarqueur de la maladie d'alzheimer
NZ599813A (en) Reagents and methods for detecting pnh type ii white blood cells and their identification as risk factors for thrombotic disorders
MX2010002993A (es) Uso de clec1b para la determinacion de riesgo cardiovascular y trombotico.
WO2020023789A3 (fr) Petits prédicteurs d'arn pour la maladie d'alzheimer
WO2005118403A3 (fr) Procedes pour detecter l'expression genique dans des cellules du sang peripherique et utilisations de ces procedes
TN2011000047A1 (en) Method of identifying disease risk factors
UA103200C2 (ru) Способ определения факторов риска заболевания на болезнь альцгеймера
EA201490548A1 (ru) Молекулярно-генетический подход для лечения и диагностики алкогольной и наркотической зависимости
WO2011163497A3 (fr) Procédé de détermination de la prédisposition à des troubles oesophagiens
PH12012502501A1 (en) Method for predicting a therapy response in subjects with multiple sclerosis